Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070)

Summary

To evaluate the LDL-C lowering in south african patients with primary hypercholesterolaemia after the addition of ezetimibe 10mg /day to ongoing therapy with a statin.

Timeline

Start

2005-04

Primary completion

2005-11

Completion

2005-11

Publications

• Results Raal F, Schamroth C, Patel J, Becker P. A multicentre, open-label, observational local study to evaluate the low-density lipoprotein cholesterol-lowering effect of ezetimibe as prescribed in daily routine practice in the South African population. Cardiovasc J Afr. 2007 Sep-Oct;18(5):325-9.

Drugs

Indications